Modulation of immunological properties of allogeneic mesenchymal stem cells by collagen scaffolds in cartilage tissue engineering

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 3, 2011, Pages 332-341

  Yuan, Tun ^a   Li, Kuifeng ^a   Guo, Likun ^a   Fan, Hongsong ^a   Zhang, Xingdong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

allogeneic engineered cartilage; collagen scaffolds; immune rejection; immunological properties; mesenchymal stem cells

Indexed keywords

COLLAGEN SCAFFOLDS; ENGINEERED CARTILAGE; IMMUNE REJECTION; IMMUNOLOGICAL PROPERTIES; MESENCHYMAL STEM CELL;

CARTILAGE; CELL CULTURE; COLLAGEN; FLOWCHARTING; HYDROGELS; STEM CELLS; STRUCTURAL PROPERTIES; TISSUE;

SCAFFOLDS (BIOLOGY);

COLLAGEN TYPE 1; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SCAFFOLD PROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE MATRIX; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNE SYSTEM; LYMPHOCYTE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; CARTILAGE; CATTLE; CELLS, CULTURED; COLLAGEN TYPE I; INTERFERON-GAMMA; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RABBITS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79960383411     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33121     Document Type: Article

References (32)

1. Chu CR, Szczodry M, Bruno S,. Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev 2009; 16: 105-115.
2. Revell CM, Athanasiou KA,. Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects. Tissue Eng Part B Rev 2009; 15: 1-15.
3. Chung C, Burdick JA,. Engineering cartilage tissue. Adv Drug Deliv Rev 2008; 60: 243-262. (Pubitemid 350236402)
4. Schulze-Tanzil G,. Activation and dedifferentiation of chondrocytes: Implications in cartilage injury and repair. Ann Anat 2009; 191: 325-338.
5. Boratynska M, Banasik M, Patrzalek D, Klinger M,. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Ann Transplant 2006; 11: 51-56.
6. Kingston RW, Goldsmith DJ,. Chronic renal allograft dysfunction: The evidence for a change in immunosuppression. Minerva Urol Nefrol 2006; 58: 23-28. (Pubitemid 43863288)
7. Chiang H, Jiang CC,. Repair of articular cartilage defects: Review and perspectives. J Formos Med Assoc 2009; 108: 87-101.
8. Pelttari K, Steck E, Richter W,. The use of mesenchymal stem cells for chondrogenesis. Injury 2008; 39 (Suppl 1): S58-S65.
9. Vinatier C, Mrugala D, Jorgensen C, Guicheux J, Noel D,. Cartilage engineering: A crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009; 27: 307-314.
10. Responte DJ, Natoli RM, Athanasiou KA,. Collagens of articular cartilage: Structure, function, and importance in tissue engineering. Crit Rev Biomed Eng 2007; 35: 363-411.
11. Mouw JK, Case ND, Guldberg RE, Plaas AH, Levenston ME,. Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering. Osteoarthritis Cartilage 2005; 13: 828-836. (Pubitemid 41263941)
12. Yang ZJ, Yuan H, Zou P, Tong W, Qu S, Zhang XD,. Osteogenic responses to extraskeletally implanted synthetic porous calcium phosphate ceramics: An early stage histomorphological study in dogs. J Mater Sci Mater Med 1997; 8: 697-701. (Pubitemid 27485099)
13. Tan YF, Hong SF, Wang XL, Lu J, Wang H, Zhang XD,. Regulation of bone-related genes expression by bone-like apatite in MC3T3-E1 cells. J Mater Sci Mater Med 2007; 18: 2237-2241. (Pubitemid 350167369)
14. Zheng L, Sun J, Chen X, Wang G, Jiang B, Fan H, Zhang X,. In vivo cartilage engineering with collagen hydrogel and allogenous chondrocytes after diffusion chamber implantation in immunocompetent host. Tissue Eng Part A 2009; 15: 2145-2153.
15. Zheng L, Fan HS, Sun J, Chen XN, Wang G, Zhang L, Fan YJ, Zhang XD,. Chondrogenic differentiation of mesenchymal stem cells induced by collagen-based hydrogel: An in vivo study. J Biomed Mater Res A 2010; 93: 783-792.
16. Whitaker IS, Duggan EM, Alloway RR, Brown C, McGuire S, Woodle ES, Hsiao EC, Maldonado C, Banis JC Jr, Barker JH,. Composite tissue allotransplantation: A review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg 2008; 61: 481-492. (Pubitemid 351635903)
17. Swearingen B, Ravindra K, Xu H, Wu S, Breidenbach WC, Ildstad ST,. Science of composite tissue allotransplantation. Transplantation 2008; 86: 627-635.
18. Watschinger B,. Indirect recognition of allo MHC peptides-Potential role in human transplantation. Nephrol Dial Transplant 1999; 14: 8-11. (Pubitemid 29041852)
19. Mohty M, Gaugler B,. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation. Cytokine Growth Factor Rev 2008; 19: 53-63.
20. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC,. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003; 75: 389-397. (Pubitemid 36222968)
21. Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris AJ,. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: Long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000; 69: 2330-2336. (Pubitemid 30408998)
22. Ravindra KV, Wu S, McKinney M, Xu H, Ildstad ST,. Composite tissue allotransplantation: Current challenges. Transplant Proc 2009; 41: 3519-3528.
23. Liu H, Kemeny DM, Heng BC, Ouyang HW, Melendez AJ, Cao T,. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol 2006; 176: 2864-2871.
24. Aggarwal S, Pittenger MF,. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822. (Pubitemid 40223708)
25. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O,. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20. (Pubitemid 38019084)
26. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH,. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595. (Pubitemid 43890897)
27. Tang KC, Trzaska KA, Smirnov SV, Kotenko SV, Schwander SK, Ellner JJ, Rameshwar P,. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. J Immunol 2008; 180: 1826-1833.
28. Kino-Oka M, Maeda Y, Yamamoto T, Sugawara K, Taya M,. A kinetic modeling of chondrocyte culture for manufacture of tissue-engineered cartilage. J Biosci Bioeng 2005; 99: 197-207. (Pubitemid 40570078)
29. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O,. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896. (Pubitemid 37211373)
30. Li Pira G, Ivaldi F, Bottone L, Quarto R, Manca F,. Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells. Hum Immunol 2006; 67: 976-985. (Pubitemid 44894637)
31. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM,. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843. (Pubitemid 34534559)
32. Le Blanc K, Pittenger M,. Mesenchymal stem cells: Progress toward promise. Cytotherapy 2005; 7: 36-45. (Pubitemid 40542402)